- Release Date: 15/10/19 11:27
- Summary: APRA consultation - subsidiary capital investment treatment
- Price Sensitive: No
- Download Document 106.1KB
- Forums
- NZX - By Stock
- ANZ
- Ann: APRA consultation - subsidiary capital investment treatment
Ann: APRA consultation - subsidiary capital investment treatment
Featured News
Add ANZ (NZSX) to my watchlist
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, CEO
Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online